Zlotorzynska et al.
JOCArticle
18.2, 17.8, -5.5, -5.6; HRMS-ESI (m/z) [M þ H]þ calcd for
(m, 0.64H), 3.20-3.07 (m, 0.66H), 2.04 (s, br, 1H), 1.95-1.69
(m, 2H), 1.50-1.19 (m, 2H), 1.16 (d, J = 6.4 Hz, 3H, cis), 1.12
(d, J = 6.4 Hz, 3H, trans), 0.90 (s, 9H), 0.05 (s, 6H); 13C NMR (100
MHz, CDCl3) δ 66.0, 65.7, 60.5, 59.2, 54.9, 53.1, 33.8, 33.6, 27.9,
25.9, 21.5, 21.1, 18.3, -5.3, -5.4; HRMS-ESI (m/z) [M þ H]þ calcd
for C12H28NOSi 230.1940, found 230.1934.
C
12H28NOSi 230.1940, found 230.1946.
2-(tert-Butyldimethylsilanyloxymethyl)-3-phenylpyrrolidine
(44b). Silyl enol ether 42b (206 mg, 0.65 mmol) was subjected
to the general cyclization procedure. Purification by flash
chromatography (67% EtOAc in hexanes) gave 155 mg
(82%) of pyrrolidine 44b (trans/cis = >95:5) as a light yellow
oil. The pyrrolidine was subjected to the general tosylation
followed by deprotection procedure and the relative stereo-
chemistry was confirmed by comparison to the desilylated
2-(tert-Butyldimethylsilanyloxymethyl)-5-phenylpyrrolidine
(48c). Silyl enol ether 47c (280 mg, 0.88 mmol) was subjected
to the general cyclization procedure. Purification by flash
chromatography (20% EtOAc in hexanes) gave 169 mg
(66%) of trans-pyrrolidine 48c as a light yellow oil. The
pyrrolidine was subjected to the general deprotection proce-
dure, and the relative stereochemistry was confirmed by
comparison to the desilylated alcohol:26 IR (neat) 3330,
alcohol:25 IR (neat) 3317, 2928, 1651, 1456, 1254 cm-1 1H
;
NMR (400 MHz, CDCl3) δ 7.33-7.18 (m, 5H), 3.71 (dd, J =
10.0, 3.2 Hz, 1H), 3.52 (dd, J = 10.0, 4.8 Hz, 1H), 3.21-3.12
(m, 2H), 3.11-3.04 (m, 1H), 2.97 (q, J = 8.8 Hz, 1H), 2.32-
2.16 (m, 2H), 2.04-1.92 (m, 1H), 0.90 (s, 9H), 0.05 (s, 3H), 0.04
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 143.9, 128.4, 127.6,
126.1, 68.5, 62.9, 46.9, 46.5, 35.7, 25.9, 18.2, -5.5; HRMS-ESI
(m/z) [M þ Na]þ calcd for C17H29NONaSi 314.1916, found
314.1911.
2928, 2856, 1673, 1462, 1255, 1112 cm-1 1H NMR (400
;
MHz, CDCl3) δ 7.41 (d, J = 7.2 Hz, 2H), 7.36 (t, J = 7.2
Hz, 2H), 7.30-7.25 (m, 1H), 4.31 (t, J = 7.2 Hz, 2H), 3.63-
3.53 (m, 3H), 2.29-2.20 (m, 1H), 2.15-2.01 (m, 2H), 1.78
(dq, J=12.4, 8.8 Hz, 1H), 1.66-1.54 (m, 1H), 0.95 (s, 9H),
0.12 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 145.4, 128.3,
126.7, 126.4, 66.2, 61.0, 59.6, 34.9, 27.8, 25.9, 18.3, -5.3;
HRMS-ESI (m/z) [M þ H]þ calcd for C17H30NOSi 292.2097,
found 292.2092.
Further elution afforded 31 mg (12%) of cis-pyrrolidine 48c
as a light yellow oil: IR (neat) 2954, 2856, 1255, 1097 cm-1; 1H
NMR (400 MHz, CDCl3) δ 7.40 (d, J =7.2 Hz, 2H), 7.32 (t, J =
7.6 Hz, 2H), 7.23 (t, J =7.2 Hz, 1H), 4.17 (t, J =7.2 Hz, 2H),
3.71 (dd, J =10.0, 4.8 Hz, 1H), 3.65 (dd, J = 10.0, 5.6 Hz, 1H),
3.53 (quin, J = 6.0 Hz, 1H), 2.20-2.10 (m, 1H), 1.94-1.81 (m,
2H), 1.75-1.65 (m, 2H), 0.92 (s, 9H), 0.09 (s, 6H); 13C NMR
(100 MHz, CDCl3) δ 144.8, 128.3, 126.8, 126.6, 66.7, 62.8, 60.3,
34.3, 27.8, 26.0, 18.4, -5.3; HRMS-ESI (m/z) [M þ H]þ calcd
for C17H30NOSi 292.2097, found 292.2090.
2-(tert-Butyldimethylsiloxymethyl)-3-methylpyrrolidine (46).
Silyl enol ether 45 (372 mg, 1.0 mmol) was subjected to the
general cyclization procedure. Purification by flash chromatog-
raphy (5% methanol in CH2Cl2) gave 300 mg (86%) of pyrro-
lidine 46 (cis/trans = 75:25) as a light yellow oil. The relative
stereochemistry was determined by analogy to pyrrolidine 48d:
IR (neat) 2928, 2856, 1472, 1463, 1361, 1252 cm-1; H NMR
1
(400 MHz, CDCl3) δ 4.36-4.31 (m, 1H), 3.64 (d, J = 5.4 Hz,
1.5H, cis), 3.57-3.35 (m, 0.25H, trans), 3.43-3.34 (m, 0.25H,
trans), 3.17-3.04 (m, 1H), 2.90-2.83 (m, 1.5H, cis), 2.76-2.58
(m, 0.40H, trans), 2.06-1.99 (m, 1H), 1.86 (br, 1H), 1.46 (ddd,
J = 10.5, 6.7, 3.8 Hz, 1H), 0.90 (s, 9H), 0.88 (s, 9H), 0.06-0.04
(m, 12H); 13C NMR (100 MHz, CDCl3) δ 73.4, 65.6, 59.8, 55.8,
38.1, 25.9, 25.8, 25.2, 18.4, 18.1, -4.8, -5.4; HRMS-ESI (m/z)
[M þ H]þ calcd for C17H40NO2Si2 346.2598, found 346.2590.
2-[(tert-Butyldimethylsilanyloxy)phenylmethyl]pyrrolidine (48a).
Silyl enol ether 47a (309 mg, 0.97 mmol) was subjected to the
general cyclization procedure. Purification by flash chromatogra-
phy (3% methanol in EtOAc) gave 131 mg (50%) of erythro
pyrrolidine 48a as a colorless oil: IR (neat) 2955, 2856, 1471, 1253,
2-(tert-Butyldimethylsilanyloxymethyl)-4-ethylpyrrolidine (48d).
Silyl enol ether 47d (69 mg, 0.26 mmol) was subjected to the general
cyclization procedure. Purification by flash chromatography
(5% methanol in EtOAc) gave 49 mg (79%) of pyrrolidine 48d
(cis/trans = 72:28) as a light yellow oil. The relative stereochem-
istry was determined by analogy to pyrrolidine 48e: IR (neat) 3300,
1
1062 cm-1; H NMR (400 MHz, CDCl3) δ 7.35-7.20 (m, 5H),
2957, 2857, 1463, 1254 cm-1 1H NMR (400 MHz, CDCl3)
;
4.45 (d, J = 6.8 Hz, 1H), 3.18 (q, J = 7.2 Hz, 2H), 3.08-2.97 (m,
1H), 2.90-2.79 (m, 1H), 2.26 (s, br 1H), 1.80-1.61 (m, 2H),
3.64-3.46 (m, 2H), 3.27-3.18 (m, 1H), 3.16 (dd, J = 10.0, 7.2
Hz, 1H, trans), 3.03 (dd, J = 10.0, 7.2 Hz, 1H, cis), 2.56 (dd, J =
10.0, 7.2 Hz, 1H, trans), 2.45 (dd, J = 10.0, 8.4 Hz, 1H, cis), 2.08
(s, br, 1H), 2.07-1.92 (m, 2H), 1.74-1.63 (m, 1H), 1.43-1.32
(m, 1H), 1.08-0.98 (m, 1H), 0.90 (d, J = 7.2 Hz, 3H), 0.09 (s, 9H),
0.06, (s, 6H); 13C NMR (100 MHz, CDCl3) δ 66.2, 65.9, 60.4, 59.6,
52.9, 52.0, 41.8, 41.0, 34.6, 34.0, 27.6, 27.4, 25.9, 18.3, 12.9, -5.4;
HRMS-ESI (m/z) [M þ H]þ calcd for C13H30NOSi 244.2097,
found 244.2092.
2-(tert-Butyldimethylsilanyloxymethyl)-4-phenylpyrrolidine
(48e). Silyl enol ether 47e (203 mg, 0.64 mmol) was subjected to
the general cyclization procedure. Purification by flash chro-
matography (5% methanol in EtOAc) gave 143 mg (77%)
of pyrrolidine 48e (cis/trans = 89:11) as a light yellow oil. The
pyrrolidine was subjected to the general tosylation followed by
deprotection procedure and the relative stereochemistry and
dr were confirmed by comparison to the desilyled alcohol:26
IR (neat) 3312, 2953, 2855, 1654, 1454, 1255 cm-1; 1H NMR
(400 MHz, CDCl3) δ 7.35-7.16 (m, 5H), 3.71 (dd, J = 10.0, 4.8
Hz, cis, 1H), 3.66 (dd, J = 10.0, 5.6 Hz, cis, 1H), 3.65 (dd, J =
10.0, 5.2 Hz, trans, 1H), 3.61 (dd, J = 10.0, 5.6 Hz, trans, 1H),
3.50-3.20 (m, 3H), 3.00-2.84 (m, 1H), 2.33-2.24 (m, 1H),
2.10-1.88 (m, 2H), 1.71-1.61 (m, 1H), 0.93 (s, 9H), 0.09
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 144.2, 144.1, 128.4,
128.0, 127.3, 127.2, 126.2, 66.0, 65.8, 60.7, 60.3, 55.4, 54.2,
1.49-1.32 (m, 2H), 0.88 (s, 9H), 0.04 (s, 3H), -0.21 (s, 3H); 13
C
NMR (100 MHz, CDCl3) δ 143.3, 128.0, 127.3, 126.8, 78.5, 66.0,
45.9, 27.2, 25.8, 24.5, 18.1, -4.5, -5.0; HRMS-ESI (m/z) [M þ
H]þ calcd for C17H30NOSi 292.2097, found 292.2091.
Further elution afforded 33 mg (12%) of pyrrolidine 48a
(erythro/threo = 50:50) as a light yellow oil: 1H NMR (400 MHz,
CDCl3) δ 7.35-7.20 (m, 5H), 4.45 (d, J = 6.8 Hz, 0.5H), 4.45 (d,
J = 6.8 Hz, 0.5H), 3.18 (q, J = 7.2 Hz, 1H), 3.21-3.19 (m, 1H),
3.08-2.97 (m, 2H), 2.91-2.73 (m, 1H), 2.03 (s, br 1H), 1.80-1.61
(m, 2H), 1.52-1.32 (m, 2H), 0.90 (s, 4.5H), 0.88 (s, 4.5H), 0.05
(s, 1.5H), 0.04 (s, 1.5H), -0.19 (s, 1.5H), -0.21 (s, 1.5H); 13C NMR
(100 MHz, CDCl3) δ 143.6, 143.3, 128.0, 127.4, 127.3, 126.8, 126.5,
78.5, 77.2, 66.2, 66.0, 46.7, 45.9, 27.2, 27.1, 25.8, 25.0, 24.5, 18.1,
-4.5, -5.0, -5.1.
2-(tert-Butyldimethylsilanyloxymethyl)-5-methylpyrrolidine (48b).
Silyl enol ether 47b (142 mg, 0.56 mmol) was subjected to the
general cyclization procedure. Purification by flash chromatography
(5% methanol in EtOAc) gave 99 mg (78%) of pyrrolidine 48b
(trans/cis = 65:35) as a light yellow oil. The relative stereochemistry
was determined by analogy to pyrrolidine 48c: IR (neat) 3364, 2927,
1645, 1462, 1379 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.64 (dd,
J = 10.0, 4.8 Hz, 0.34H, cis), 3.56 (dd, J = 10.0, 4.8 Hz, 0.34H, cis),
3.51-3.45 (m, 1.3H, trans), 3.38-3.29 (m, 0.64H), 3.27-3.20
(25) Miura, K.; Hondo, T.; Nakagawa, T.; Takahashi, T.; Hosomi, A.
Org. Lett. 2000, 2, 385–388.
(26) Momotake, A.; Togo, H.; Yokoyama, M. J. Chem. Soc., Perkin
Trans. 1 1999, 1193–1200.
J. Org. Chem. Vol. 75, No. 3, 2010 871